Encare has entered into a partnership with the National Cancer Institute of Thailand (NCI Thailand) in Bangkok, marking the start of structured ERAS® implementation at a specialist oncology hospital within Thailand’s public healthcare system.
The collaboration focuses on colorectal surgery, with NCI Thailand adopting the ERAS® Interactive Audit System (EIAS) to support protocol implementation, compliance tracking, and continuous audit. The partnership was signed in May 2026.
Bringing structured perioperative care to Thailand
ERAS® protocols are evidence-based guidelines designed to reduce surgical stress, improve recovery, and shorten hospital stays. Implementing them at scale requires more than clinical agreement: it requires structured data collection, team alignment, and a way to measure whether protocols are being followed consistently over time.
EIAS provides that infrastructure. By tracking compliance at the patient and protocol level, clinical teams can identify where implementation is strong and where it needs reinforcement, supporting both improvement and accountability.
A foundation for ERAS® Qualification
NCI Thailand’s stated objective is to work toward recognition as an ERAS® Qualified Center. ERAS® Qualification is independently assessed and awarded by the ERAS® Society, and is open to hospitals that can demonstrate sustained, measurable compliance with ERAS® protocols over time. EIAS is the audit system used to generate the data required for that assessment.
“Implementing Enhanced Recovery After Surgery (ERAS®) protocols has transformed routine cancer care throughout the entire surgical pathway. Furthermore, the ERAS® Interactive Audit System (EIAS) enables splendid, real-time data analysis, driving comprehensive improvements across clinical teams and healthcare societies.“, says Dr. Hathaiwan Moungthard, Oncology Surgeon at affiliated with medical facilities such as National Cancer Institute.
Dr. Hathaiwan Moungthard and her team at the Department of Surgery, National Cancer Institute of Thailand
“The National Cancer Institute of Thailand is an important first hospital partner for Encare as we enter the Thai market. The collaboration gives us an opportunity to support ERAS® implementation at a specialist oncology hospital within Thailand’s public healthcare system. We look forward to working with the NCI team as it introduces the guidelines in colorectal surgery,” says Rasmus Waller, CEO of Encare.
The partnership begins with colorectal surgery. Additional surgical specialties may follow as implementation matures.
Read the full press release: Encare signs agreement with National Cancer Institute of Thailand to support ERAS® implementation – Encare
About the National Cancer Institute of Thailand
The National Cancer Institute of Thailand is a specialist oncology hospital in Bangkok, operating under the Department of Medical Services, Ministry of Public Health. It provides diagnosis, treatment, and research across a broad range of cancer types.
www.nci.go.th
About Encare
Encare AB is a Swedish healthtech company and the sole global commercial partner of the ERAS® Society. The partnership was established in 2010 and runs through 2039. Encare provides the ERAS® Interactive Audit System (EIAS), which enables hospitals to measure adherence to evidence-based perioperative care guidelines, track outcomes and identify areas for improvement. Together with trainers appointed by the ERAS® Society, Encare supports hospitals through the ERAS® Implementation Program (EIP) and towards ERAS® Qualification. Today, Encare works with more than 140 hospitals across more than 30 countries, with more than 130,000 ERAS® surgical procedures registered in EIAS since 2010.
www.encare.net
